DPM-1003

N/A

Report date: 2024/03/20 15:14:11
NME

Base Information

Drug NameDPM-1003
Drug Alias NameDPM-1003DPM1003
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein-tyrosine phosphatase 1B inhibitors
TargetsProtein-tyrosine phosphatase 1B
Therapy Area/IndicationsRett Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesMaxia Strategies-Europe Ltd
China Registration ClassN/A

Develop Information

Active CompaniesMaxia Strategies-Europe LtdDepymed Inc
Inactive CompaniesN/A
Active IndicationsRett Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A